4-methoxy-4'-nitro-thiobenzanilide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-methoxy-4'-nitro-thiobenzanilide
• 英文别名: 4-Methoxy-4'-nitrothiobenzanilide；4-methoxy-N-(4-nitrosulfanylphenyl)benzamide
• 化学式: C₁₄H₁₂N₂O₄S
• 分子量: 304.326
• InChiKey: WUVCCKVIHKFCKY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  109
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  4-methoxy-4'-nitro-thiobenzanilide 在 sodium hydroxide 、 potassium hexacyanoferrate(III) 作用下， 以 乙醇 、 水 为溶剂， 以130 mg (26%)的产率得到6-甲氧基-2-(4-硝基苯基)苯并噻唑
  参考文献：
  名称：

  Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and vivo imaging and prevention of amyloid deposition

  摘要：

  这项发明涉及新型噻吩啉衍生物，使用这些衍生物的方法，例如用于体内成像患有神经纤维斑块的患者，包括噻吩啉衍生物的药物组合物以及合成这些化合物的方法。这些化合物在诊断和治疗患有神经纤维斑块积聚疾病的患者中发现特定用途。这些疾病状态或疾病包括但不限于阿尔茨海默病、家族性阿尔茨海默病、唐氏综合征以及载脂蛋白E4等位基因的纯合子。

  公开号：

  US20020133019A1

文献信息

• Novel 4H-1,2,4-triazole derivatives
  申请人：Roussel Uclaf

  公开号：US04659729A1

  公开（公告）日：1987-04-21

  Compounds selected from the group consisting of 4H-1,2,4-triazoles of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 may be in different positions of the benzene ring, R.sub.1, R.sub.3 and R.sub.4 are individually selected from the group consisting of hydrogen, --OH, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, halogen, --CF.sub.3, --NO.sub.2, --NH.sub.2 and NH--AlK and ##STR2## R.sub.2 is selected from the group consisting of hydrogen, --OH, alkyl of 1 to 4 carbon atoms, halogen, --CF.sub.3, --NO.sub.2, --NH.sub.2, --NH--AlK and ##STR3## and AlK, AlK.sub.1 and AlK.sub.2 are alkyl of 1 to 4 carbon atoms or R.sub.1 and R.sub.2 together and/or R.sub.3 and R.sub.4 together are methylenedioxy, R is selected from the group consisting of ethyl, --CH.sub.2 --COOH and CH.sub.2 --COOAlK.sub.3 and AlK.sub.3 is alkyl of 1 to 4 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts, with the proviso that R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are not all hydrogen having a remarkable analgesic activity and a novel method for their preparation.

  从4H-1,2,4-三唑类化合物中选择的化合物，其化学式为##STR1##其中R.sub.1，R.sub.2，R.sub.3和R.sub.4可能位于苯环的不同位置，R.sub.1，R.sub.3和R.sub.4分别选自氢，-OH，1至4个碳原子的烷基，1至4个碳原子的烷氧基，卤素，-CF.sub.3，-NO.sub.2，-NH.sub.2和NH-AlK和##STR2##R.sub.2选自氢，-OH，1至4个碳原子的烷基，卤素，-CF.sub.3，-NO.sub.2，-NH.sub.2，-NH-AlK和##STR3##和AlK，AlK.sub.1和AlK.sub.2是1至4个碳原子的烷基，或R.sub.1和R.sub.2一起和/或R.sub.3和R.sub.4一起是亚甲二氧基，R选自乙基，-CH.sub.2-COOH和CH.sub.2-COOAlK.sub.3的群，AlK.sub.3是1至4个碳原子的烷基及其无毒、药用可接受的酸盐，但R.sub.1，R.sub.2，R.sub.3和R.sub.4不能都是具有显著镇痛活性和新颖制备方法的氢。
• 4,5-Bis(aryl)-4H-1,2,4-triazole derivatives and analgesic use
  申请人：Roussel Uclaf

  公开号：US04512997A1

  公开（公告）日：1985-04-23

  Novel 4H-1,2,4-triazoles of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 may be in different positions of the benzene rings and are individually selected from the group consisting of hydrogen, --OH, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, halogen, --CF.sub.3, --NO.sub.2, --NH.sub.2 and --NH--AlK and ##STR2## and AlK, AlK.sub.1 and AlK.sub.2 are alkyl of 1 to 4 carbon atoms or R.sub.1 and R.sub.2 together and/or R.sub.3 and R.sub.4 together are methylenedioxy, R is selected from the group consisting hydrogen, alkyl of 1 to 4 carbon atoms, --CH.sub.2 --COOH and --CH.sub.2 --COOAlK.sub.3 and AlK.sub.3 is alkyl of 1 to 4 carbon atoms and their non-toxic, pharmaceutically acceptable acid addition salts having a remarkable analgesic activity and a novel method for their preparation.

  4H-1,2,4-三唑类新化合物的分子式为##STR1##其中R.sub.1、R.sub.2、R.sub.3和R.sub.4可以位于苯环的不同位置，分别选择自氢、--OH、1至4个碳原子的烷基、1至4个碳原子的烷氧基、卤素、--CF.sub.3、--NO.sub.2、--NH.sub.2和--NH--AlK和##STR2##以及AlK，AlK.sub.1和AlK.sub.2是1至4个碳原子的烷基，或者R.sub.1和R.sub.2一起和/或R.sub.3和R.sub.4一起是亚甲二氧基，R选择自氢、1至4个碳原子的烷基、--CH.sub.2 --COOH和--CH.sub.2 --COOAlK.sub.3，AlK.sub.3是1至4个碳原子的烷基，它们的无毒、药学上可接受的酸盐具有显著的镇痛活性，以及它们的制备新方法。
• Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
  申请人：UNIVERSITY OF PITTSBURGH

  公开号：US20030236391A1

  公开（公告）日：2003-12-25

  This invention relates to novel thioflavin derivatives, methods of using the derivatives in, for example, in vivo imaging of patients having neuritic plaques, pharmaceutical compositions comprising the thioflavin derivatives and method of synthesizing the compounds. The compounds find particular use in the diagnosis and treatment of patients having diseases where accumulation of neuritic plaques are prevalent. The disease states or maladies include but are not limited to Alzheimer's disease, familial Alzheimer's disease, Down's Syndrome and homozygotes for the apolipoprotein E4 allele.

  这项发明涉及新型噻吩染料衍生物，以及使用这些衍生物进行例如体内成像患有神经节细胞斑块的患者、包含这些噻吩染料衍生物的药物组合物和合成这些化合物的方法。这些化合物在诊断和治疗患有神经节细胞斑块积聚病变的患者中具有特殊用途。这些疾病状态或疾病包括但不限于阿尔茨海默病、家族性阿尔茨海默病、唐氏综合症和载有apolipoprotein E4等位基因的纯合子。
• [EN] A METHOD OF DIAGNOSING PRODROMAL FORMS OF DISEASES ASSOCIATED WITH AMYLOID DEPOSITION<br/>[FR] PROCÉDÉ DE DIAGNOSTIC DE FORMES PRODROMIQUES DE MALADIES ASSOCIÉES AU DÉPÔT AMYLOÏDE
  申请人：UNIV PITTSBURGH

  公开号：WO2006014382A1

  公开（公告）日：2006-02-09

  A method of identifying a patient as prodromal to a disease associated with amyloid deposition by imaging techniques is provided. In addition, a method of identifying amyloid deposition diseases in patients who present with a dementing disorder of questionable etiology by imaging techniques is provided. The methods discloses substances which are used for imaging and generating data which can be used to determine progress of an asymptomatic patient to a disease associated with amyloid deposition. or to identify amyloid deposition diseases in patients who present with a dementing disorder of questionable etiology.

  提供了一种通过成像技术将患者识别为与淀粉样沉积相关的疾病的前驱的方法。此外，还提供了一种通过成像技术识别出患有疑似病因的痴呆症状的患者中存在淀粉样沉积疾病的方法。该方法公开了用于成像和生成数据的物质，这些数据可用于确定无症状患者发展为与淀粉样沉积相关的疾病的进展，或者用于识别出患有疑似病因的痴呆症状的患者中存在淀粉样沉积疾病。
• In Vivo or in Vitro Method For Detecting Amyloid Deposits Having at Least One Amyloidogenic Protein
  申请人：Klunk William E.

  公开号：US20080305040A1

  公开（公告）日：2008-12-11

  An amyloid deposit can be detected by administering to a subject or applying to a sample a compound of Formula (I) or Formula (II) or structures 1-45, as described, and then imaging to detect binding of the compound to an amyloid deposit, where the amyloido genie protein of the deposit can be AL, AH, ATTR, Aβ2M, AA, AApoAI, AApoAII, AGeI, ALys, AFib, ACys, ABri, ADan, APrP, ACaI, AlAPP, AANF, APro, AIns, AMed, AKer, A(tbn), and/or ALac.

  通过向受试者施用或将化合物I式或II式或结构1-45应用于样本，并进行成像以检测化合物与淀粉样沉积物的结合，可以检测到淀粉样沉积物。其中，沉积物的淀粉基因蛋白可以是AL、AH、ATTR、Aβ2M、AA、AApoAI、AApoAII、AGeI、ALys、AFib、ACys、ABri、ADan、APrP、ACaI、AlAPP、AANF、APro、AIns、AMed、AKer、A(tbn)和/或ALac。